Table 2 Description of subsample participants
Variable | Intervention M (SD) or N (%) | Control M (SD) or N (%) |
|---|---|---|
Age (years) | 57.23 (9.24) | 57.38 (8.53) |
Male | 57 (43.2%) | 65 (46.8%) |
Race/Ethnicity | ||
Non-Hispanic white | 66 (50.0%) | 67 (48.2%) |
Black | 49 (37.1%) | 55 (39.6%) |
Hispanic | 8 (6.1%) | 5 (3.6%) |
Other | 9 (6.8%) | 10 (7.2%) |
Non-Hispanic, missing race | 0 (0.0%) | 2 (1.4%) |
Income | ||
> $55,000 | 35 (26.5%) | 33 (23.7%) |
$25,000-$54,499 | 34 (25.8%) | 36 (25.9%) |
$10,000-$24,999 | 33 (25.0%) | 36 (25.9%) |
< $9999 | 20 (15.2%) | 25 (18.0%) |
Missing | 10 (7.6%) | 9 (6.5%) |
Years of School | 14.15 (2.74) | 14.38 (3.42) |
Insurance Status | ||
Private Insurance | 73 (55.3%) | 76 (54.7%) |
Public Insurance | 34 (25.8%) | 33 (23.7%) |
Insured – Type Unknown | 2 (1.5%) | 1 (0.7%) |
Uninsured | 23 (17.4%) | 29 (20.9%) |
Diabetes Duration (years) | 11.65 (7.73) | 11.26 (7.73) |
Baseline HbA1c (%) | 8.46 (1.68) | 8.55 (1.82) |
Baseline eGFR | 77.12 (22.49) | 77.99 (22.41) |
Categorical Baseline eGFR | ||
Stage 1 (> 90 mL/min) | 43 (32.6%) | 50 (36.0%) |
Stage 2 (60-89.9 mL/min) | 60 (45.5%) | 53 (38.1%) |
Stage 3A (45-59.9 mL/min) | 15 (11.4%) | 27 (19.4%) |
Stage 3B (30-44.9 mL/min) | 12 (9.1%) | 6 (4.3%) |
Stage 4 (15-29.9 mL/min) | 2 (1.5%) | 3 (2.2%) |
Baseline Albuminuria | ||
Normal (negative dipstick, ACR < 30 mg/g, or microalbumin < 30 mg/dL) | 100 (75.8%) | 97 (69.8%) |
Mild (1+ dipstick, 30-300 mg/g ACR, or microalbumin > = 30 mg/dL) | 24 (18.2%) | 33 (23.7%) |
Heavy (2+ dipstick, > 300 mg/g ACR) | 8 (6.1%) | 9 (6.5%) |